Notice of Award of a Single-Source Cooperative Agreement To Fund the Kinshasa School of Public Health, Democratic Republic of the Congo (KSPH, DRC), 975-976 [2022-00078]
Download as PDF
<![CDATA[
975
Federal Register / Vol. 87, No. 5 / Friday, January 7, 2022 / Notices
This a new two-year ATSDR
information collection request (ICR) for
a collaborative study between the
Centers for Disease Control and
Prevention’s National Center for
Environmental Health (CDC/NCEH) and
ATSDR. This follow-up study will
recruit participants who; (1)
participated in a previous ATSDRfunded study, (2) have existing serumPFAS measurements, and (3) have given
prior consent for additional contact
from NCEH/ATSDR. We anticipate that
the total number of participants enrolled
in the CDC/ATSDR cohorts will be
around 3,170 (2,800 adults and 370
children) individuals. This study will
attempt to enroll the entire universe of
eligible participants; therefore, our
target sample size is 3,170. The cohorts
have a substantial number of
participants with high PFAS exposure,
as well as a sufficient range of serumPFAS concentrations to allow
examination of associations between the
outcomes and across a wide range of
PFAS exposures.
The objectives are the following: (1)
To examine the association between
serum-PFAS collected through the EAs,
PEATT assessments, and Pease Study
and the frequency of occurrence of
selected syndromes (combinations of
self-reported symptoms), which will be
used as a proxy for viral infections; and,
(2) to examine the association between
serum-PFAS collected through the EAs,
PEATT assessments, and Pease Study
and self-reported positive test results
indicating specific viral infections.
During the first three months of the
two-year study period, NCEH/ATSDR
will invite and consent approximately
3,170 participants (2,800 adults and 370
children) to complete a new series of
surveys to determine whether PFAS
exposure increases susceptibility to
viral infections, including, but not
limited to COVID–19. Data will be
collected from those who enroll in the
study through an initial paper-based
survey and a series of four additional
surveys over a 12- to 14-month period.
Follow-up surveys will be offered in
two modes: Web-based and paper-based.
It is estimated that 75% of the
participants will choose the web-based
mode. Participants will also be given
symptom diaries to improve recall after
the initial and between each of the
follow-up surveys.
The total time burden requested is
19,816 hours (or 9,908 hours annually).
There are no costs to the respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Form name
Adults ......................................
Initial Questionnaire—Adult (paper) .......................................
Follow up Questionnaire—Adult (paper) ................................
Follow up Questionnaire—Adult (REDCap) ...........................
Symptom Diary .......................................................................
Initial Questionnaire—Child (paper) .......................................
Follow up Questionnaire—Child (paper) ................................
Follow up Questionnaire—Child (REDCap) ...........................
Symptom Diary .......................................................................
Initial Questionnaire—Child (paper) .......................................
700
175
525
700
70
18
52
70
12
1
4
4
1
1
4
4
1
1
30/60
30/60
25/60
4
30/60
30/60
25/60
4
30/60
Follow up Questionnaire—Child (paper) ................................
Follow up Questionnaire—Child (REDCap) ...........................
Symptom Diary .......................................................................
6
18
23
4
4
1
30/60
25/60
4
Children (7–17 years) .............
Parents of Children (3–6
years).
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–00101 Filed 1–6–22; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
tkelley on DSK125TN23PROD with NOTICE
Number of
respondents
Type of respondent
Notice of Award of a Single-Source
Cooperative Agreement To Fund the
Kinshasa School of Public Health,
Democratic Republic of the Congo
(KSPH, DRC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice.
VerDate Sep<11>2014
17:08 Jan 06, 2022
Jkt 256001
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $700,000, with
an expected total funding of $3,500,000
over a five-year period, to the Kinshasa
School of Public Health, Democratic
Republic of the Congo (KSPH DRC). The
award will support the investigation of
the epidemiological, ecological, and
anthropological aspects of monkeypox
and assess clinical intervention
strategies in the Democratic Republic of
Congo (DRC). These activities align with
CDC priorities to promote surveillance
and global health to prevent the
international spread of diseases and to
control them at the source.
DATES: The period for this award will be
September 30, 2022, through September
29, 2027.
FOR FURTHER INFORMATION CONTACT: Dr.
Amy Yang, National Center for HIV,
Viral Hepatitis, STD, and TB Prevention
SUMMARY:
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
(NCHHSTP), Centers for Disease Control
and Prevention, 1600 Clifton Road NE,
MS US8–1, Atlanta, GA 30329–4027,
Telephone: 404–718–8835, Email: corp_
erpo_8835@cdc.gov.
This
single-source award will support the
investigation of the epidemiological,
ecological, and anthropological aspects
of monkeypox and assess clinical
intervention strategies in the DRC.
Research activities will focus on
improvement and evaluation of labbased surveillance systems,
investigations of animal reservoirs and
human behaviors at the human-animal
interface, epidemiologic investigations,
genome sequencing and phylogenetic
analysis, risk mitigation, enhancing
health communication strategies, and
clinical evaluation of vaccines and
therapeutic treatments. The research
should provide the DRC Ministry of
Health and other key stakeholders with
evidence-based strategies to develop
SUPPLEMENTARY INFORMATION:
E:\FR\FM\07JAN1.SGM
07JAN1
976
Federal Register / Vol. 87, No. 5 / Friday, January 7, 2022 / Notices
monkeypox and other zoonotic disease
interventions.
The Kinshasa School of Public Health,
Democratic Republic of the Congo
(KSPH, DRC) is in a unique position to
conduct this work, as it has a distinct
role in the public health system of DRC
by being both an institute of the
University of Kinshasa and previously
serving as the bone fide agent of the
Ministry of Health; is the implementing
partner for an open label trial of
JYNNEOS smallpox vaccine in the
healthcare workers of Tshuapa Province
(2017–present), a study that will
continue under the new cooperative
agreement; along with their partners at
the University of Kinshasa, has 10 years
of experience in conducting rigorous
investigations of potential monkeypox
reservoir species; and has continually
maintained a field office in Tshuapa
Province devoted to monkeypox
surveillance and research since 2011.
This longstanding commitment to
working in this area has yielded the
most thorough longitudinal dataset on
monkeypox incidence globally since
smallpox eradication. No other
indigenous or foreign institution has
been able to sustain a continual field
site for this length of time in a
monkeypox-endemic area of DRC.
Summary of the Award
tkelley on DSK125TN23PROD with NOTICE
Recipient: The Kinshasa School of
Public Health, Democratic Republic of
the Congo (KSPH, DRC).
Purpose of the Award: The purpose of
this award is to investigate the
epidemiological, ecological, and
anthropological aspects of monkeypox
and assess clinical intervention
strategies in the Democratic Republic of
Congo (DRC). This research may extend
to other zoonotic and vaccinepreventable diseases that are of
importance in the DRC and elsewhere.
Amount of Award: $700,000 in
Federal Fiscal Year (FYY) 2022 funds,
and an estimated $700,000 for each
subsequent 12-month budget period
over five years, subject to availability of
funds.
Authority: This program is authorized
under Public Health Service Act,
Sections 301(a) [42 U.S.C. 241(a)] and
307 [42 U.S.C. 242l].
Period of Performance: September 30,
2022, through September 29, 2027.
Dated: January 4, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–00078 Filed 1–6–22; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:08 Jan 06, 2022
Jkt 256001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–0213; Docket No. CDC–2022–
0004]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled National Vital Statistics Report
(NVSR) Form. The NVSR Forms collects
annual statistics on marriage and
divorce and is used to permit
uninterrupted tracking of family
dynamics.
SUMMARY:
Written comments must be
received on or before March 8, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0004 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
DATES:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below. The
OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
National Vital Statistics Report
(NVSR) Forms (OMB Control No. 0920–
0213, Exp. 10/31/2023)—Revision—
National Center for Health Statistics
(NCHS), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The compilation of national vital
statistics dates back to the beginning of
the 20th century and has been
conducted since 1960 by the Division of
Vital Statistics of the National Center for
Health Statistics (NCHS), CDC. The
collection of data is authorized by 42
U.S.C. 242k. This submission requests
to continue use of the Annual Vital
E:\FR\FM\07JAN1.SGM
07JAN1
]]>Agencies
[Federal Register Volume 87, Number 5 (Friday, January 7, 2022)]
[Notices]
[Pages 975-976]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00078]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
the Kinshasa School of Public Health, Democratic Republic of the Congo
(KSPH, DRC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $700,000, with an expected total funding of
$3,500,000 over a five-year period, to the Kinshasa School of Public
Health, Democratic Republic of the Congo (KSPH DRC). The award will
support the investigation of the epidemiological, ecological, and
anthropological aspects of monkeypox and assess clinical intervention
strategies in the Democratic Republic of Congo (DRC). These activities
align with CDC priorities to promote surveillance and global health to
prevent the international spread of diseases and to control them at the
source.
DATES: The period for this award will be September 30, 2022, through
September 29, 2027.
FOR FURTHER INFORMATION CONTACT: Dr. Amy Yang, National Center for HIV,
Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention, 1600 Clifton Road NE, MS US8-1, Atlanta, GA
30329-4027, Telephone: 404-718-8835, Email: [email protected].
SUPPLEMENTARY INFORMATION: This single-source award will support the
investigation of the epidemiological, ecological, and anthropological
aspects of monkeypox and assess clinical intervention strategies in the
DRC. Research activities will focus on improvement and evaluation of
lab-based surveillance systems, investigations of animal reservoirs and
human behaviors at the human-animal interface, epidemiologic
investigations, genome sequencing and phylogenetic analysis, risk
mitigation, enhancing health communication strategies, and clinical
evaluation of vaccines and therapeutic treatments. The research should
provide the DRC Ministry of Health and other key stakeholders with
evidence-based strategies to develop
[[Page 976]]
monkeypox and other zoonotic disease interventions.
The Kinshasa School of Public Health, Democratic Republic of the
Congo (KSPH, DRC) is in a unique position to conduct this work, as it
has a distinct role in the public health system of DRC by being both an
institute of the University of Kinshasa and previously serving as the
bone fide agent of the Ministry of Health; is the implementing partner
for an open label trial of JYNNEOS smallpox vaccine in the healthcare
workers of Tshuapa Province (2017-present), a study that will continue
under the new cooperative agreement; along with their partners at the
University of Kinshasa, has 10 years of experience in conducting
rigorous investigations of potential monkeypox reservoir species; and
has continually maintained a field office in Tshuapa Province devoted
to monkeypox surveillance and research since 2011. This longstanding
commitment to working in this area has yielded the most thorough
longitudinal dataset on monkeypox incidence globally since smallpox
eradication. No other indigenous or foreign institution has been able
to sustain a continual field site for this length of time in a
monkeypox-endemic area of DRC.
Summary of the Award
Recipient: The Kinshasa School of Public Health, Democratic
Republic of the Congo (KSPH, DRC).
Purpose of the Award: The purpose of this award is to investigate
the epidemiological, ecological, and anthropological aspects of
monkeypox and assess clinical intervention strategies in the Democratic
Republic of Congo (DRC). This research may extend to other zoonotic and
vaccine-preventable diseases that are of importance in the DRC and
elsewhere.
Amount of Award: $700,000 in Federal Fiscal Year (FYY) 2022 funds,
and an estimated $700,000 for each subsequent 12-month budget period
over five years, subject to availability of funds.
Authority: This program is authorized under Public Health Service
Act, Sections 301(a) [42 U.S.C. 241(a)] and 307 [42 U.S.C. 242l].
Period of Performance: September 30, 2022, through September 29,
2027.
Dated: January 4, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2022-00078 Filed 1-6-22; 8:45 am]
BILLING CODE 4163-18-P
